Revolution Medicines, Inc. Gains 41.35%
Mon, Apr 13, 2026 at 07:25 PM
Revolution Medicines, Inc. (RVMD:NASDAQ) jumped higher at $136.3, a gain of 41.3%. On Mon, Apr 13, 2026, RVMD:NASDAQ hit a New 2-Week High of $136.3. The stock got featured on our News Catalysts scanner on Mon, Apr 13, 2026 at 05:52 PM in the 'BIOTECH' category. From Mon, Mar 30, 2026, the stock recorded 77.78% Up Days and 50.00% Green Days
About Revolution Medicines, Inc. (RVMD:NASDAQ)
Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products include RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio, and SOS1 and 4EBP1/mTORC1 programs.
Top 10 Gainers:
- Real Messenger Corporation (RMSG:NASDAQ), 475.08%
- Rectitude Holdings Ltd (RECT:NASDAQ), 85.83%
- RedCloud Holdings plc (RCT:NASDAQ), 77.19%
- Virax Biolabs Group Limited (VRAX:NASDAQ), 59.85%
- Bitcoin Depot Inc. (BTM:NASDAQ), 49.81%
- DevvStream Corp. (DEVS:NASDAQ), 49.6%
- Lichen International Limited (LICN:NASDAQ), 41.88%
- Momentus Inc. (MNTS:NASDAQ), 41.38%
- Revolution Medicines, Inc. (RVMD:NASDAQ), 41.35%
- Jeffs' Brands Ltd (JFBR:NASDAQ), 40%